Many chemokines are present at the maternal-fetal interface and play important roles in the establishment and maintenance of pregnancy. Our study demonstrates that a chemokine, chemokine (C-C motif) ligand 28 (CCL28), is expressed in the uterine endometrium during early pregnancy in pigs. Thus, we investigated expression of CCL28 and its receptors, chemokine (C-C motif) receptor types 3 (CCR3) and 10 (CCR10), in the uterine endometrium during the estrous cycle and pregnancy and the function of CCL28 at the maternal-fetal interface during early pregnancy. Levels of CCL28 mRNAs were highest on Day 10 of pregnancy and decreased thereafter during pregnancy, and CCL28 was localized mainly to endometrial glandular epithelial cells. The presence of the CCL28 protein in uterine flushings was confirmed on Day 12 of the estrous cycle and pregnancy. Endometrial tissues expressed CCR3 and CCR10 during pregnancy. The CCR10 protein was localized to endometrial luminal and glandular epithelial cells, chorionic epithelial cells, and the allantoic membrane during pregnancy. Conceptuses during early pregnancy expressed CCL28 and CCR10, but not CCR3, and chorioallantoic tissues expressed CCR10 at increasing levels towards term. Treatment with recombinant CCL28 increased the proliferation and migration of a porcine trophectoderm cell line. These results indicated that the CCL28 chemokine and its receptors, CCR3 and CCR10, are expressed at the maternalconceptus interface, and CCL28 induces the proliferation and migration of trophectoderm cells through CCR10, suggesting that CCL28 may play a critical role in the establishment and maintenance of pregnancy in pigs.
INTRODUCTION
Chemokines, chemotactic cytokines, are a large group of small peptide ligands that are divided into four subfamilies, C, CC, CXC, and CX3C, according to their structure [1] . Chemokines are involved in various cell functions, including proliferation, differentiation, migration, and apoptosis [2] [3] [4] . The best-characterized functions of chemokines are the stimulation of migration of immune cells to target tissues and the regulation of immune cell functions [5] . The receptors for chemokines are G-protein-coupled receptors, and more than 20 receptors have been identified to date [1] . Most chemokine ligands interact with more than one receptor, suggesting redundant effects on the target cells [2, 4] .
It has been suggested that chemokines are involved in the establishment of pregnancy in several species [2, 6] . Chemokine (CX3C motif) ligand 1 (CX3CL1) and chemokine (CC motif) ligand 14 (CCL14) are expressed in the human endometrium at high levels at the time of implantation and increase migration and adhesion of trophoblast cells by inducing expression of extracellular matrix (ECM) and adhesion molecules [7, 8] . Chemokine (CXC motif) ligand 8 (CXCL8) stimulates trophoblast migration as well as trophoblast invasion by inducing production of matrix metalloproteases and integrins [9] . CXCL12 is expressed by endometrial cells in humans [10] , sheep [11] , and cattle [12] , and by invading trophoblasts in humans [13] . It functions in the recruitment of decidual natural killer cells and the maintenance of Th2 cytokine production by endometrial immune cells during early pregnancy [14, 15] . In pigs, it has been reported that many chemokines, including CCLs and CXCLs, and their receptors are expressed in the uterine endometrium [16, 17] . Recently, using a microarray analysis, we found that CCL28 is expressed in the uterine endometrium during pregnancy in pigs [18] . However, the detailed expression and function of CCL28 at the maternal-fetal interface are not fully understood in pigs.
CCL28, also called mucosa-associated epithelial chemokine (MEC), is a 12-kDa protein composed of 127 amino acids and is expressed by epithelial cells on several mucosal tissues [19, 20] . CCL28 can bind to two different receptors, C-C chemokine receptor 3 (CCR3) and CCR10 [21, 22] . CCR3 has been shown to be expressed in several types of leukocytes, such as eosinophils, basophils, mast cells, and a subset of peripheral blood T lymphocytes [23] . However, in addition to CCL28, CCR3 can also bind to many other CCL ligands, including CCL5, CCL7, CCL8, CCL11, CCL13, CCL15, CCL24, and CCL26 [4] . CCR10 is expressed by several cell types, including dermal microvascular endothelial cells, fibroblasts, epidermal keratinocytes, and skin-homing T cells in skin [24, 25] ; IgA-secreting B cells; and a subset of T lymphocytes in various tissues [26] [27] [28] . Upon binding to CCR3 or CCR10, CCL28 attracts leukocytes, such as IgA-secreting cells, T cells, and eosinophils, into the mucosal tissues, including intestine, lung, mammary gland, skin, and salivary gland [28] [29] [30] .
Although the expression and function of CCL28 and its receptors have been heavily studied in many mucosal tissues, there is little information available on the expression and function of CCL28 in the uterine endometrium. Therefore, to initiate the studies on the role of CCL28 in the uterine endometrium in pigs, we determined 1) the expression of CCL28 and its receptors, CCR3 and CCR10, in the uterine endometrium during the estrous cycle and pregnancy; 2) the cell-specific localization of CCL28 and CCR10 in the uterine endometrium; 3) expression of CCL28, CCR3, and CCR10 in conceptus during early pregnancy; 4) secretion of CCL28 protein into the uterine lumen; and 5) the effects of CCL28 on proliferation and migration of conceptus trophectoderm cells.
MATERIALS AND METHODS

Animals and Tissue Preparation
All experimental procedures involving animals were conducted in accordance with the Guide for Care and Use of Research Animals in Teaching and Research and approved by the Institutional Animal Care and Use Committee of Yonsei University. Sexually mature crossbred female pigs were assigned randomly to either cyclic or pregnant status. The reproductive tracts of gilts were obtained immediately after slaughter on Days 12 and 15 of the estrous cycle and Days 10, 12, 15, 30, 60, 90, and 114 of pregnancy (n ¼ 3-6 gilts/day/status). Pregnancy was confirmed by the presence of apparently normal filamentous conceptuses in uterine flushings on Days 12 and 15 and the presence of embryos and placenta on the later days of pregnancy. Uterine flushings were obtained by introducing and recovering 50 ml of PBS (pH 7.4) from the uterus (25 ml/uterine horn). Conceptus tissues on Day 12 and Day 15 of pregnancy were obtained from uterine flushings, and chorioallantoic tissues were obtained from Days 30, 60, 90, and 114 of pregnancy (n ¼ 3-4/day). The flushings were clarified by centrifugation (3000 3 g for 10 min at 48C), aliquoted, and frozen at À808C until analyzed.
Endometrium, dissected free of myometrium, was collected from the middle portion of each uterine horn, snap frozen in liquid nitrogen, and stored at À808C for RNA extraction. For in situ hybridization analysis and immunohistochemistry, cross sections of endometrium were fixed in 4% paraformaldehyde in PBS (pH 7.4) for 24 h and then embedded in paraffin as previously described [31] .
Total RNA Extraction and RT-PCR for the CCL28, CCR3, and CCR10 cDNAs Total RNA was extracted from endometrial, chorioallantoic, and conceptus tissues and peripheral blood mononuclear cells (PBMC) using TRIzol reagent (Invitrogen) according to the manufacturer's recommendations. The quantity of RNA was assessed spectrophotometrically, and the integrity of RNA was validated following electrophoresis in a 1% agarose gel.
Four micrograms of total RNA from endometrial and chorioallantoic tissues and 1 lg from conceptus tissues were treated with DNase I (Promega) and reverse transcribed using SuperScript II Reverse Transcriptase (Invitrogen) to obtain cDNAs. The cDNA templates were then diluted 1:4 with nuclease-free water and amplified by PCR using Taq polymerase (Takara Bio). The PCR conditions and sequences of the primer pairs are listed in Table 1 . The PCR products were separated on a 2% agarose gel and visualized by ethidium bromide staining. The identity of each amplified PCR product was verified by sequence analysis after cloning into the pCRII vector (Invitrogen).
Quantitative Real-Time RT-PCR
To analyze levels of the CCL28, CCR3, and CCR10 mRNAs in the uterine endometrium, real-time RT-PCR was performed using the Applied Biosystems StepOnePlus System using the SYBR Green method. Complementary DNAs were synthesized from 4 lg of total RNA isolated from different uterine endometrial tissues, and newly synthesized cDNAs (total volume of 21 ll) were diluted 1:4 with nuclease-free water and then used for PCR. The Power SYBR Green PCR Master Mix (Applied Biosystems) was used for PCR reactions. The final reaction volume of 20 ll included 2 ll of cDNA, 10 ll of 23 Master Mix, 2 ll of each primer (100 nM), and 4 ll of distilled H 2 O. The PCR conditions and the sequences of the primer pairs are listed in Table 1 . The results are reported as expression relative to the level detected on Day 12 of the estrous cycle after normalization of the transcript amount to the endogenous porcine ribosomal protein L7 (RPL7) control by the 2 ÀDDCT method [32] .
Nonradioactive In Situ Hybridization
The nonradioactive in situ hybridization procedure was performed as described previously with some modifications [33] . Sections (5 lm thick) were rehydrated through successive baths of xylene, 100% ethanol, 95% ethanol, diethyl pyrocarbonate (DEPC)-treated water, and DEPC-treated PBS. Tissue sections were permeabilized with DEPC-treated PBS containing 0.3% Triton X-100 for 15 min. After washing in DEPC-treated PBS, they were digested using 5 lg/ml proteinase K (Sigma) in TE (100 mM Tris-HCl, 50 mM EDTA, pH 7.5) at 378C. After fixation in 4% paraformaldehyde, sections were incubated twice for 15 min each in PBS containing 0.1% active DEPC and equilibrated for 15 min in 53 saline-sodium citrate (SSC). The sections were prehybridized for 2 h at 688C in hybridization mix (50% formamide, 53 SSC, 500 lg/ml herring sperm DNA; 200 ll on each section). Sense and antisense CCL28 riboprobes labeled with digoxigenin (DIG)-UTP were denatured for 5 min at 808C and added to the hybridization mix. The hybridization reaction was carried out at 688C overnight. Prehybridization and hybridization reactions were performed in a box saturated with a 53 SSC-50% formamide solution to avoid evaporation, and no coverslips were used. After hybridization, sections were washed for 30 min in 23 SSC at room temperature, 1 h in 23 SSC at 658C, and 1 h in 0.13 SSC at 658C. Probes bound to the sections were detected immunologically using sheep anti-DIG Fab fragments covalently coupled to CHOI ET AL.
alkaline phosphatase and nitro blue tetrazolium chloride/5-bromo-4-chloro-3-indolyl phosphate (toluidine salt) as the chromogenic substrate, according to the manufacturer's protocol (Roche).
Immunoblot Analysis
Uterine flushings were concentrated using centrifugal filters with pore sizes of molecular weight of 10 000 according to the manufacturer's recommendations (Millipore). Fifty-five micrograms of protein from concentrated uterine flushings and 0.5 lg of recombinant human CCL28 protein (rCCL28; R&D Systems) as a control were loaded into and electrophoresed on 12% SDS-PAGE gels followed by electrotransfer onto nitrocellulose membranes. Nonspecific binding was blocked with 5% (w/v) fat-free milk in Tris-buffered saline with 0.1% (v/v) Tween-20 (TBST) buffer for 1 h at room temperature. The blot was incubated overnight at 48C with 0.5 lg/ml mouse monoclonal anti-CCL28 antibody (R&D Systems) or mouse isotype control IgG 1 (Abcam) diluted in 2% bovine serum albumin/TBST. The blot was washed in TBST at room temperature three times for 10 min each, incubated with peroxidaseconjugated goat antimouse secondary antibody (1:10 000; Jackson Laboratories) for 1 h at room temperature, and rinsed again with TBST for 30 min at room temperature. Immunoreactive proteins were detected by chemiluminescence (SuperSignal West Pico; Pierce Chemical Co.) according to the manufacturer's recommendations using x-ray film (Agfa-Gevaert).
Immunohistochemistry
To determine which cells in the porcine endometrium expressed CCR10, sections were immunostained. Sections (5 lm thick) were deparaffinized and rehydrated in an alcohol gradient. Tissue sections were washed with PBS with 0.1% (v/v) Tween-20 (PBST) and blocked with 0.5% (v/v) H 2 O 2 in methanol for 30 min. Tissue sections were then blocked with 10% normal goat serum for 30 min at room temperature. Rabbit anti-CCR10 antibody (5 lg/ml; LifeSpan BioSciences) was added and incubation was carried out overnight at 48C in a humidified chamber. For each tissue tested, purified normal rabbit IgG was substituted for the primary antibody as a negative control. Tissue sections were washed with PBST. Biotinylated goat antirabbit secondary antibody (1:5000; Vector Laboratories) was added and sections were incubated for 1 h at room temperature. Following washes with PBST, a streptavidin peroxidase conjugate (Invitrogen) was added to the tissue sections, which were then incubated for 10 min at room temperature. The sections were washed with PBST, and aminoethyl carbazole substrate (Invitrogen) was added to the tissue sections, which were then incubated for 20 min at room temperature. The tissue sections were washed in water, counterstained with Mayer hematoxylin, and coverslipped.
Porcine Trophectoderm Cell Culture
The mononuclear porcine trophectoderm (pTr) cell line established from Day 12 conceptuses used in the present in vitro studies was described previously [34] [35] [36] . Briefly, the pTr cells were cultured in phenol red-free Dulbecco modified Eagle medium/F-12 culture medium (DMEM/F-12; Sigma) that included 10% fetal bovine serum (Gibco BRL), 1% Zell Shield (Minerva Biolabs), 0.1 mM each nonessential amino acid, 1 mM sodium pyruvate, 2 mM glutamine, and 0.7 lM insulin in an atmosphere of 5% CO 2 in air at 378C. When the density of cells in the dishes reached approximately 80% confluency, they were passaged at a ratio of 1:3, and frozen stocks of cells were prepared at each passage. For the experiments, monolayer cultures of pTr cells (between passages 9 and 13) were grown in culture medium to 80% confluency in 100-mm tissue culture plates.
pTr Cell Proliferation Assay
The pTr cells were subcultured in 24-well plates at 50% confluency in DMEM/F-12, serum starved for 24 h, and then treated with 0, 0.1, 1, 10, or 100 ng/ml rCCL28 at 378C for 48 h. Cell numbers were determined as described previously [35, 36] . Briefly, the medium was removed from cells by vacuum aspiration and the cells were fixed in 50% ethanol for 30 min, followed by vacuum aspiration of the fixative. Fixed cells were stained with a Janus Green B in PBS (0.2% w/v) for 3 min at room temperature. The stain was removed immediately using a vacuum aspirator, and the whole plate was sequentially dipped into water and destained by gentle shaking. The remaining water was removed by shaking, the stained cells were immediately lysed in 0.5 N HCl, and absorbance readings were taken at 595 nm using a microplate reader. As described previously [36, 37] , cell numbers were calculated from absorbance readings using the following formula: cell number ¼ (absorbance À 0.00462)/ 0.00006926. The entire experiment was independently replicated three times with different batches of pTr cells.
pTr Cell Migration Assay
Migration assays were conducted with pTr cells as described previously [38] . Briefly, pTr cells (50 000 cells per 100 ll serum-free medium) were seeded on 8-lm-pore Transwell inserts (Corning-Costar). Each well (n ¼ 3 replicates/treatment) was treated with 0, 10, or 100 ng/ml rCCL28. One microgram per milliliter recombinant mouse SPP1 (rSPP1; Sigma) was used as a positive control. After 12 h, cells remaining on the upper side of the inserts were removed with a cotton swab. For evaluation of the cells that migrated onto the lower surface, inserts were fixed in 50% ethanol for 5 min. The Transwell membranes were then removed, placed on a glass slide with the side containing cells facing up, stained with Prolong antifade mounting reagent with 4 0 ,6-diamidino-2-phenylindole (Invitrogen-Molecular Probes), and coverslipped. The migrated cells were systematically counted in five nonoverlapping locations that covered approximately 70% of the insert membrane growth area using a Zeiss Axioplan 2 fluorescence microscope with an Axiocam HR digital camera and Axiovision 4.3 software (Carl Zeiss Microimaging). The entire experiment was repeated three times.
Transfection of Target-Specific siRNAs
To determine whether pTr cell proliferation induced by rCCL28 was mediated by activation of CCR10, pTr cells were treated with control (Silencer Negative Control 1 siRNA with no homology to any known gene; Ambion) or CCR10 siRNA duplex (sense 5 0 -GCUUCCUCUUCCUGGCCUGUAUCA-3 0 and antisense 5 0 -UGAUACAGGCCAGGAAGAGGAAGC-3 0 ; Bioneer). Transfection of siRNA was performed according to the manufacturer's suggested procedure. Briefly, 1 day prior to transfection with siRNA, pTr cells (2 3 10 4 ) in medium were plated in each well of six-well plates. The next day, the media was aspirated from the wells and replaced with 1.5 ml of media without antibiotics and 500 ll of siRNA-Lipofectamine 2000 (Invitrogen) complex. For each well transfected with siRNA-Lipofectamine 2000 complex, one tube was prepared containing Lipofectamine 2000 diluted to 250 ll with serum-free Opti-MEM medium (#31985; Gibco) and was allowed to incubate for 5 min. In a second tube, siRNA was diluted to 250 ll with Opti-MEM to a final concentration of 10-500 pM per plate. The diluted siRNA and Lipofectamine 2000 were combined, mixed by pipetting, and incubated for 20 min at room temperature to allow for complex formation. For each plate, 500 ll of Lipofectamine 2000-siRNA complex mixture was added to the cells. The cells were incubated for 6 h, the medium was replaced with fresh growth medium with serum to remove the transfection reagent, and the cells were incubated for an additional 48 h. Total cellular RNA was isolated from transfected cells and subjected to quantitative real-time RT-PCR analysis. To analyze the effect of CCR10 knockdown on rCCL28-induced proliferation of pTr cells, 0 or 10 ng/ml rCCL28 was added to the culture medium after the siRNA transfection (500 pM control or CCR10 siRNA), and the incubation was continued for another 48 h. Using green fluorescein-conjugated control siRNA duplexes (Cell Signaling Technology), we estimated that greater than 95% of the cells were successfully transfected.
Statistical Analysis
Data from real-time RT-PCR for the analysis of CCL28, CCR3, and CCR10 expression during the estrous cycle and pregnancy and data from the cell proliferation and migration assays were subjected to least-squares ANOVA using the General Linear Models procedures of SAS. As sources of variation, the model included day, pregnancy status (cyclic or pregnant), and their interactions (day 3 status) to evaluate the steady-state level of CCL28, CCR3, and CCR10 mRNAs, and treatment and replication to evaluate the effect of rCCL28 on cell proliferation and migration. The effects of the day of pregnancy (Days 12, 15, 30, 60, 90, and 114) in the endometrium and effects of the day of pregnancy (Days 30, 60, 90, and 114) in chorioallantoic tissue for data from real-time RT-PCR for CCL28 and CCR10 expression were analyzed by least-squares regression analysis. Data are presented as least-squares means with SEM.
RESULTS
Expression of CCL28 mRNA in Uterine Endometrium During the Estrous Cycle and Pregnancy and the Presence of the CCL28 Protein in the Uterine Lumen in Pigs
To determine whether CCL28 mRNA is expressed in the uterine endometrium during the estrous cycle and pregnan-CCL28 IN THE UTERINE ENDOMETRIUM IN PIGS cy, we measured the relative abundance of CCL28 mRNA in uterine endometrium during the estrous cycle and pregnancy using real-time RT-PCR analysis. Real-time RT-PCR analysis indicated that the expression of CCL28 mRNA was affected by day (P , 0.05), but not by pregnancy status, and that their interaction on Days 12 and 15 postestrus and the levels of CCL28 mRNA during pregnancy were highest on Day 12 and decreased thereafter (linear effect of day, P , 0.05) (Fig. 1A) .
To determine the localization of the CCL28 mRNA expressed in uterine endometrium, we performed an in situ hybridization analysis. As shown in Figure 1B , expression of CCL28 mRNA was found predominantly in glandular epithelial (GE) cells in the uterine endometrium. FIG. 1 . Expression of CCL28 in the porcine uterine endometrium during the estrous cycle and pregnancy. A) Real-time RT-PCR analysis of CCL28 mRNA in the uterine endometrium. Endometrial tissue samples from cyclic and pregnant gilts were analyzed by real-time RT-PCR, and the data are reported as expression relative to that detected on Day 12 of the estrous cycle after normalization of the transcript amount to the endogenous RPL7 control. B) In situ hybridization analysis of CCL28 mRNA in the uterine endometrium. Expression of CCL28 mRNA was localized mainly to endometrial GE cells during the estrous cycle and pregnancy. Representative uterine sections from Day 12 of pregnancy, hybridized with a DIG-labeled sense CCL28 cRNA probe (Sense) as a negative control, are shown. D, day; C, estrous cycle; P, pregnancy; LE, luminal epithelium; GE, glandular epithelium; St, stroma; BV, blood vessels. Bars ¼ 200 lm and 100 lm in inset. C) Immunoblot analysis of the CCL28 protein in uterine flushings on Day 12 of the estrous cycle and pregnancy. Uterine flushings were obtained from Day (D) 12 of the estrous cycle (C) and pregnancy (P) and the presence of the CCL28 protein was determined. We loaded rCCL28 as a positive control.
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Because CCL28 was expressed in the endometrial GE cells, we asked whether the CCL28 protein was secreted into the uterine lumen. To answer this, we obtained uterine flushings from Day 12 of the estrous cycle and pregnancy and analyzed proteins from the uterine flushings using immunoblot analysis. As shown in Figure 1C , CCL28 protein was detected in uterine flushings on Day 12 of the estrous cycle and pregnancy. Immunohistochemical analysis of CCL28 could not be done because of the lack of available antibodies that work in immunohistochemistry to detect the porcine CCL28 protein.
Expression of the CCL28 Receptors CCR3 and CCR10 in Uterine Endometrium During the Estrous Cycle and Pregnancy in Pigs
After we had determined that CCL28 is expressed in the uterine endometrium during the estrous cycle and pregnancy, the next set of experiments was done to determine the expression of the CCL28 receptors, CCR3 and CCR10, in uterine endometrium. Real-time RT-PCR analysis showed that the expression of CCR3 mRNA on Days 12 and 15 postestrus was not affected by day and pregnancy status, but was affected by day 3 status interaction (P , 0.05), and was greater on Day 15 of pregnancy than on Day 15 of the estrous cycle. The steady-state levels of CCR3 mRNA during pregnancy did not change ( Fig. 2A) . The expression of CCR10 mRNA on Days 12 and 15 postestrus was affected by day (P , 0.001) and day 3 status interaction (P , 0.01), but not by pregnancy status, and was greater on Day 12 of the estrous cycle than on Day 12 of pregnancy. The steady-state levels of CCR10 mRNA during pregnancy were highest on Day 12 and decreased thereafter (linear effect of day, P , 0.05) (Fig. 2B) .
The localization of CCR10 protein in the porcine endometrium during the estrous cycle and pregnancy was determined by immunohistochemistry (Fig. 3) . CCR10 protein was localized mainly to uterine GE cells and weakly to luminal epithelial cells (LE) on Days 12 and 15 of the estrous cycle. Interestingly, strong CCR10 protein signals were detected at the basal side of LE on Day 15 of pregnancy. CCR10 protein was also detected at the basal side of chorionic epithelial cells (CM) and in the allantoic membrane (AM) during mid to late pregnancy. In particular, CCR10 protein during Day 60 to term pregnancy was mainly localized to CM in areolar areas. Immunohistochemical analysis of CCR3 could not be done because of the lack of available antibodies that detect the porcine CCR3 protein in immunohistochemistry.
Expression of CCL28, CCR3, and CCR10 mRNAs in Conceptuses During Early Pregnancy and Chorioallantoic Tissues During the Later Stage of Pregnancy
Next, we performed RT-PCR using cDNA from conceptuses from Days 12 and 15 of pregnancy and found CCL28 and CCR10, but not CCR3, mRNAs to be detectable in conceptuses from both days of pregnancy (Fig. 4A) . Because CCR10 mRNA was detected in conceptuses during early pregnancy, we further determined the localization of the CCR10 protein in conceptus tissues on Day 12 of pregnancy. As shown in Figure  4B , immunohistochemical studies revealed that CCR10 protein was localized to the conceptus trophectoderm.
To determine if the levels of CCR10 mRNA changed in chorioallantoic tissues during mid to late pregnancy, a real-time RT-PCR analysis was performed. As shown in Figure 4C , analysis of the levels of CCR10 mRNA in chorioallantoic tissues on Days 30, 60, 90, and 114 of pregnancy revealed that the abundance of CCR10 mRNA increased from Day 30 to term pregnancy (linear effect of day, P , 0.01).
Effect of CCL28 on the Proliferation and Migration of pTr Cells
Because the endometrial expression levels of CCL28 mRNA during pregnancy were highest on Day 12, CCL28 proteins are secreted into the uterine lumen, and expression of CCR10 was detectable in conceptus trophectoderm during
FIG. 2. Expression of CCR3
(A) and CCR10 (B) in the porcine uterine endometrium during the estrous cycle and pregnancy. Endometrial tissue samples from cyclic and pregnant gilts were analyzed by real-time RT-PCR, and the data are reported as expression relative to that detected on Day 12 of the estrous cycle after normalization of the transcript amount to the endogenous RPL7 control. The levels of CCR3 mRNA were not changed during pregnancy, whereas the levels of CCR10 mRNA during pregnancy were highest on Day 12 and decreased thereafter (linear effect of day, P , 0.05). The data are presented as least-squares means with SEM.
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early pregnancy, we focused on the role of CCL28 during early pregnancy and hypothesized that CCL28 may affect conceptus trophectoderm cell function. First, we determined if pTr cells, a primary pTr cell line derived from Day 12 conceptus [34] , expressed CCR3 and CCR10 mRNAs, and found that CCR10, but not CCR3, mRNA was expressed in pTr cells as well as in the PBMC used as a positive control (Fig. 5A) . Next, to understand the function of CCL28 in conceptus development during early pregnancy, we analyzed the effect of CCL28 protein on proliferation of pTr cells. As shown in Figure 5B , treatment with rCCL28 significantly increased the proliferation of pTr cells at doses of 1, 10 (P , 0.01), and 100 ng/ml (P , 0.05). Furthermore, we determined the effect of CCL28 on the migration of pTr cells. Treatment with 10 and 100 ng/ml rCCL28 significantly increased the migration of pTr cells compared to the control (0 ng/ml) (P , 0.01). Treatment of pTr cells with 1 lg/ml rSPP1 as a positive control [38] also increased the migration of pTr cells.
Effect of Inhibition of CCR10 Expression by CCR10 siRNA on pTr Cell Proliferation
Because pTr cells expressed CCR10, and rCCL28 induced proliferation of pTr cells, we hypothesized that the CCL28-induced proliferation of pTr cells was mediated by CCR10. To confirm this hypothesis, we transfected CCR10 siRNA into pTr cells, treated with rCCL28, and measured cell proliferation. As shown in Figure 6A , to evaluate the efficiency of CCR10 siRNA, we treated pTr cells with increasing doses (0, 10, 100, or 500 pM) of control or CCR10 siRNAs and found that 100 and 500 pM CCR10 siRNA efficiently reduced the expression of CCR10 mRNA in pTr cells (P , 0.01). Next, we treated with combinations of control siRNA (500 pM), CCR10 siRNA (500 pM), and rCCL28 (10 ng/ml) and measured the proliferation of pTr cells. As shown in Figure 6B , rCCL28 significantly increased pTr cell proliferation in the presence or absence of control siRNAs (P , 0.01), whereas the rCCL28-induced pTr cell proliferation was significantly decreased by treatment with CCR10 siRNA.
DISCUSSION
The novel findings of this study are that 1) CCL28 is expressed in the uterine endometrium in a pregnancy stage-and cell type-dependent manner; 2) CCR3 and CCR10 are expressed in the uterine endometrium during the estrous cycle and pregnancy; 3) CCR10, but not CCR3, is expressed in conceptus tissues; 4) CCL28 is secreted into the uterine endometrium on Day 12 of the estrous cycle and pregnancy; and 5) rCCL28 binds CCR10 and increases proliferation and migration of a conceptus trophectoderm cell line. This is the first report to characterize the expression of the CCL28 chemokine and its receptors CCR3 and CCR10 at the maternalconceptus interface and the role of CCL28 on trophectoderm cell function in pigs.
CCL28 is typically expressed by epithelial cells in many mucosal tissues, including lung, intestine, and mammary gland [21, 22] . In this study, we showed that CCL28 expression was also detected in the porcine uterus during the estrous cycle and pregnancy. The expression levels of endometrial CCL28 were higher during early pregnancy than during the mid to late stage of pregnancy, as we showed in our previous study [18] . Furthermore, in this study, we showed that CCL28 was expressed in endometrial epithelial cells, especially in GE, of the uterus. The fact that CCL28 was expressed by GE suggested that the CCL28 protein was secreted into the uterine lumen. Indeed, CCL28 protein was detectable in uterine flushings from Day 12 of the estrous cycle and pregnancy, suggesting that CCL28 may act as a histotroph for conceptus development during early pregnancy. The expression level of CCL28 in the uterine endometrium on Day 12 of pregnancy is not different from the level on Day 12 of the estrous cycle. Also, levels of CCL28 expression in the endometrium between Days 10 and 12 of pregnancy are not different. Thus, it seems 
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that factors from the conceptus may not play a significant role in the expression of CCL28 in the uterine endometrium during early pregnancy. Further studies will be needed to elucidate the mechanisms underlying the regulation of endometrial expression of CCL28 in pigs.
It is known that CCL28 action in diverse physiological processes is mediated through its receptors, CCR3 and CCR10 [21, 22] . Expression of CCR3 has been shown in several types of leukocytes, such as eosinophils, basophils, mast cells, and a subset of peripheral blood T lymphocytes [23] . In human endometrium, it has been shown that CCR3 is expressed in GE, decidual stromal cells, leukocytes, endothelial cells, and vascular smooth muscle cells of endometrial blood vessels [7, 39] . In this study, we found that CCR3 was expressed in the porcine uterine endometrium, and its expression was higher on Day 15 of pregnancy than on Day 15 of the estrous cycle. Localization of CCR3 expression in the porcine uterus still needs further study. Expression of CCR10 mRNA was detected in the uterine endometrium, and the pattern of endometrial CCR10 expression during pregnancy was similar to that of CCL28 expression; the levels of endometrial CCR10 expression were higher during early pregnancy than during the mid to late stage of pregnancy. In addition to several cell types, including immune cells, fibroblasts, and endothelial cells, expression of CCR10 has been demonstrated in epithelial cells in lung and skin [19, 21, 26, 29] . In this study we also found that CCR10 was expressed in endometrial epithelial cells in the porcine uterus, and that expression of CCR10 protein was localized mainly to GE during the estrous cycle and early pregnancy, as well as to LE on Day 15 of pregnancy, suggesting autocrine and paracrine mechanisms of CCL28 function.
It has been shown that 1,25-dihydroxy vitamin D3, the active form of vitamin D, increases expression CCR10 in terminally differentiating B cells [40] and cultured T cells [41] . However, the regulatory mechanism of CCR3 and CCR10 expression is not well understood. Interestingly, CCR3 expression was higher on Day 15 of pregnancy than on Day 15 of the estrous cycle, and CCR10 protein was detected in the basal side of LE on Day 15 of pregnancy, which is the time when secretion of interferon-c (IFNG) and interferon-d from conceptuses is at the highest levels in pigs [42] , suggesting the possibility of a role for these IFNs in CCR3 and CCR10 expression on Day 15 of pregnancy. In fact, our preliminary data show that increasing doses of IFNG increase CCR3 and CCR10 expression in endometrial explants (Choi and Ka, unpublished data). Further studies will be needed to determine whether 1,25-dihydroxy vitamin D3 affects endometrial CCR10 expression and what factor(s) are involved in expression of CCR3 and CCR10 in the uterine endometrium during the estrous cycle and pregnancy.
Expression of various chemokine receptors in trophoblast cells has been reported in several species, including humans, mice, sheep, and pigs [2, 6, 12, 16] . Additionally, it has been reported that CCR10 is expressed in the syncytiotrophoblast layer of human placenta [43, 44] . Our study showed that CCR3 expression was not detected in conceptus tissues during early pregnancy, whereas CCR10 expression was detectable in conceptus trophectoderm on Day 12 of pregnancy and in epithelial cells of the chorioallantoic membrane from Day 30 to term pregnancy. The levels of CCR10 mRNA in the chorioallantoic membrane increased toward term pregnancy. Although the levels of CCR28 mRNA decreased toward term during pregnancy, the expression of CCR10 in trophectoderm cells and in the chorioallantoic membrane suggests that the CCL28-CCR10 system may play an important role in the development of placental tissues in pigs.
Secretion of CCL28 by the uterine endometrium, the absence of CCR3 expression in conceptus tissues, and the presence of CCR10 in conceptus trophectoderm led us to postulate that CCL28 may act on trophectoderm cell development through CCR10 during pregnancy. Indeed, our data showed that CCL28 increased the proliferation of porcine primary trophectoderm cells. Furthermore, by blocking CCR10 expression using CCR10 siRNA, we confirmed that the CCL28-induced increase in cell proliferation was mediated through CCR10. Porcine conceptuses undergo dramatic morphological changes during early pregnancy, changing from spherical to tubular to elongated filamentous shape between Days 10 and 12 of pregnancy [42] . Although porcine conceptuses rarely proliferate during elongation [45] , proliferation of elongated conceptuses has been shown by proliferating cell nuclear antigen staining during Days 12-15 of pregnancy [34] . Thus, the results of the current study suggest that CCL28 produced by the uterine endometrium may be involved in the proliferation of conceptus trophectoderm.
Attachment of trophectoderm to the maternal endometrial epithelial cells and cell migration in the uterus are key features 1, 10 , or 100 ng/ml rCCL28 at 378C for 48 h in triplicate. C) Effect of rCCL28 on pTr cell migration. Serum-starved pTr cells were seeded on 8-lm-pore Transwell inserts and treated with different doses (0, 10, or 100 ng/ml) of rCCL28 or 1 lg/ml of rSPP1 as a positive control in triplicate for 12 h. Unmigrated cells on the upper side of the inserts were removed, and cells that had migrated were counted systematically in five nonoverlapping locations. Each independent experiment for cell proliferation and migration was replicated three times. The asterisks denote statistically significant differences (*P , 0.05; **P , 0.01).
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of the implanting conceptus in mammals [42, 46, 47] . These processes involve many ECM proteins and cell adhesion molecules, such as integrins. Elongated porcine conceptuses undergo extensive cytoskeletal reorganization for hypertrophy and migration during the implantation period [45] . One of the well-characterized ECM proteins involved in cell adhesion and migration of conceptus trophectoderm is secreted phosphoprotein 1 (SPP1; also called osteopontin) [48] . SPP1 has been shown to induce ovine trophectoderm cell migration by binding to integrins and activating the mTOR (mechanistic target of rapamycin) signaling pathway [38, 49] . In this study, SPP1 induced the migration of porcine primary trophectoderm cells. Moreover, we found that CCL28 could also induce migration of porcine primary trophectoderm cells. Because CCL28 is a type of chemokine known to function in the recruitment of leukocytes into mucosal tissues, it is not surprising that CCL28 functions as an inducer of the migration of trophectoderm cells.
The most well-known function of CCL28 is to recruit immune cells, such as IgA-secreting B cells, T cells, and eosinophils, into the mucosal tissues [28] [29] [30] 50] ; however, whether CCL28 recruits immune cells into the uterine endometrium was not determined in this study and will need further study. Interestingly, our results showed that CCR10 expression is localized to epithelial cells in the porcine uterine endometrium, suggesting a role for CCL28 in endometrial epithelial cell function. Because it has been shown that CCR10 is expressed by keratinocytes and mediates keratinocyte proliferation and migration during re-epithelization in wounded epidermis [25] , one may speculate that CCL28 affects the maintenance or reorganization of epithelial cells by regulating epithelial cell proliferation in the endometrium; this also needs further study. Furthermore, it has been reported that CCL28 can also act as an antibacterial peptide in mucosal immunity [51, 52] . The human and mouse CCL28 proteins have shown antibacterial activity against several bacterial species, including Candida albicans, Streptococcus pyogenes, and Staphylococcus aureus [51] , and the porcine CCL28 protein has been shown to effectively kill enteric bacteria species, such as Salmonella Choleraesuis, Salmonella Dublin, and Escherichia coli [52] . Because CCL28 proteins were present in uterine flushings on Day 12 of the estrous cycle and pregnancy, it is possible that CCL28 may also act as an antimicrobial protein to protect the uterine endometrium from the bacterial infection.
In summary, results of this study demonstrated that the CCL28 chemokine and its receptor CCR10 are expressed in a pregnancy stage-and cell type-specific manner in the uterine endometrium, and that CCL28 acts on proliferation and migration of pTr cells. Although the many other functions of CCL28 on immune cell recruitment and antimicrobial activity in the uterine endometrium are not fully understood, our findings in this study suggest that CCL28 may play an important role in proliferation and migration of conceptuses during the implantation period in pigs.
